Qiliqiangxin(QLQX),as an innovative traditional Chinese medicine developed under the guidance of Luobing theory,has seen increasing evidence over the past 20 years supporting its pharmacological mechanisms in treating heart failure and improving cardiovascular outcomes,significantly reducing cardiovascular endpoint e-vents.However,the pharmacological mechanisms of QLQX in the treatment of chronic heart failure(CHF)are not yet well known among clinicians.This expert consensus aims to further standardize and guide the rational use of QLQX in patients with heart failure,summarizing the compositional characteristics and pharmacological mecha-nisms of QLQX for treating CHF,and providing recommendations for its clinical application.
NETL
NSTL
万方数据
